2024 International Congress Archives - Page 17 of 181

Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach

M. Hildaria, D. Tunjungsari, A. Tiksnadi (Central Jakarta, Indonesia)
Targeting miR-27 with Antisense Oligonucleotides for Disease Modification in Parkinson’s Disease

L. Ponsati, S. Hansen, M. Scharff, H. Klitgaard, S. Kauppinen, E. Bezard, J. Erler (København SV, Denmark)
Task-Based Functional Imaging in Task-Specific Focal Dystonia during Dystonia-Related and -Unrelated Tasks

B. Huynh, Y. Wang, M. Chen, E. Narinsky, YL. Kuo, T. Kimberley (Boston, USA)
Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.

X. Li, FT. Liu (Shanghai, China)
TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease

J. Deliz, N. Lancki, D. Larson (CHICAGO, USA)
Telemonitoring-assisted DBS Optimization For Parkinson’s Disease Patients

C. Sidiropoulos, F. Kanellos, N. Kostikis, G. Rigas, S. Konitsiotis (Thessaloniki, Greece)
Temporal coordination of head and trunk during 360-degree turning in Parkinson’s Disease

PIB. Burgos, FBH. Horak, CSB. Silva-Batista, PCK. Carlson-Kuhta, AR. Ragothaman, VVS. Shah, MM. Mancini (Portland, USA)
Temporal prediction in cervical dystonia

L. Avanzino, A. Botta, M. Putzolu, G. Bonassi, C. Cosentino, S. Mezzarobba, E. Ravizzotti, E. Pelosin, S. Terranova (Genova, Italy)
Tension Pneumocephalus as an acute complication of STN-DBS surgery

E. Rosa Fernandes, L. Bassani Devens, G. Dick Bonato, J. Junqueira Bizzi, L. Frighetto, P. Petry Oppitz, S. Trentin, B. Fraiman Oliveira, Y. Felloni Borges (Porto Alegre, Brazil)
Territorial inventory of training needs in nursing home for the support of patients with Parkinson’s syndrome

J. Thezenas (Eaubonne, France)
Tetradystonics patients may be misdiagnosed?

J. Duarte, H. Teive, F. Tensini, F. Germiniani (Curitiba, Brazil)
The “Cat Killer’s Disease”: Lived Experience of Parkinson’s disease Patients in Ethiopia

S. Seyoum, S. Gugssa, R. Walker, N. Fothergill-Misbah, W. Mersha, S. Kifelew (Addis Ababa, Ethiopia)
The 2-Minute Walking Test Predicts Aerobic Fitness, Motor Function, and Brain Health in Parkinson’s Disease

E. Uc, V. Magnotta, E. Axelson, J. Dawson, M. Mani, A. Comellas, J. Kline, N. Narayanan, D. Mcgehee, S. Anderson, C. Weber, W. Darling (Iowa City, USA)
The 201 Trial in Untreated Parkinson’s Disease

M. Werner, CW. Olanow, A. Mcgarry, C. Meyer, E. Mancino, C. Klint, J. Pellecchia (Atlanta, USA)
The AIMS Clinic Model: A Retrospective Analysis of Interdisciplinary Neuropalliative Care for People with Advanced Parkinsonism

M. Husain, D. Shankar, A. Hong, S. Chen, S. Kee, K. Gustashaw, G. Hong, N. Kramer, J. Fleisher (Chicago, USA)
The alteration of GABA and glutamate in Parkinson’s disease is related to motor executive dysfunction: a 7T-MRS study

D. Su, N. Wei, R. Yan, Z. Zhang, T. Feng (Beijing, China)
The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)
The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry

O. Odeniyi, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Lagos, Nigeria)
The Association of Pain with motor symptom severity in Parkinson’s Disease: A secondary data analysis

N. Pacheco-Barrios, V. Gagliardi, R. Grudtner, I. Njokanma, K. Acurio, J. Rolston, B. Illigens, F. Fregni, K. Pacheco-Barrios (Boston, USA)
The association of Severity and Monogenetic Subgroups in Parkinson’s Disease

N. Pacheco-Barrios, K. Acurio, J. Rolston, T. Siepman, B. Illigens (Boston, USA)
The Black and African American Connections to Parkinson’s Disease Study

F. Akcimen, P. Crea, P. Saffie-Awad, S. Grant, R. Traurig, M. Khani, M. Makarious, K. Levine, D. Vitale, M. Koretsky, M. Nalls, Z. Fang, J. Solle, N. Louie, O. Ojo, N. Okubadejo, G. Sukumar, C. Dalgard, R. Real, H. Morris, K. Billingsley, P. Jerez, D. Hernandez, S. Arepalli, L. Malik, A. Miano-Burkhardt, H. Leonard, H. Iwaki, C. Blauwendraat, A. Singleton, S. Bandres-Ciga (Bethesda, USA)
The bypassing and embedded PEG J

R. Edward, O. Mitchell, W. Han, G. Singh Alg (London, United Kingdom)
The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

KC. Dey, D. Mair, A. Zirra, E. Camboe, T. Zannat, S. Haque, RS. Weil, DA. Gallagher, C. Budu, T. Haque, S. Ali, N. Mukadam, A. Habib, AJ. Noyce, CR. Marshall, S. Waters (London, United Kingdom)
The challenge to prevent Parkinson’s Disease with a new in vitro approach

C. Dalla Verde, S. Gazzin, C. Tiribelli (Trieste, Italy)
The Challenges of Adaptive Deep Brain Stimulation: A Delphi Panel Study

M. Guidetti, T. Bocci, M. de Pedro, G. Deuschl, A. Fasano, R. Martinez Fernandez, C. Gasca-Salas, C. Hamani, J. Krauss, A. Kühn, P. Limousin, S. Little, A. Lozano, N. Maiorana, M. Okun, S. Oliveri, J. Ostrem, E. Scelzo, A. Schnitzler, P. Starr, Y. Temel, L. Timmermann, G. Tinkhauser, V. Visser-Vandewalle, J. Volkmann, A. Priori (Milan, Italy)
The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China

YF. Cheng, HF. Shang (Chengdu, China)
The Characteristics and Management of Patients with Dystonia Referred for The Troubleshooting of Deep Brain Stimulation Therapy: A Single Center Experience

J. Yu, F. Sarmento, J. Lobo Lopes, A. Daga, A. Wang, T. de Araujo, A. Ramirez-Zamora, J. Wong (Gainesville, USA)
The Clinical and Genetic Characteristics of HSP Patients by WES Sequencing Combined with MLPA

YW. Cao, HR. Zheng, ZY. Zhu, L. Yao, WT. Tian, L. Cao (Shanghai, China)
The clinical features, neuroimagings and outcomes of diabetic striatopathy: a retrospective study at tertiary hospital in Vietnam

T. Nguyen, N. Nguyen, K. Le, K. Nguyen, T. Tran (Ho Chi Minh, Viet Nam)
The Clinical Implication of Dysphagia in Patients with Multiple System Atrophy

MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Seoul, Republic of Korea)
The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)
The comorbidity conundrum in functional movement disorder: How are FMD patients with additional other FND different?

S. Desai, A. Shah, D. Desai (Anand, India)
The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

A. Rosal, A. Strafella, S. Martin (Toronto, Canada)
The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic

E. Spasova, C. O'Keeffe, A. Blanco-Campal, J. Inocentes, C. Fearon, R. Reilly (Dublin, Ireland)
The course of cognitive impairment in Parkinson’s disease patients with Сovid-19

R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)
The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)

S. Hirczy, Y. Lin, C. Zabetian (Seattle, USA)
the Degeneration of Locus Coeruleus and its Enhanced Causal Relationship to Neural Circuit in Parkinson’s Tremor

JY. Sun (Beijing, China)
The dementia with Lewy bodies related metabolic brain pattern (DLBRP) – a multicentric validation

M. Perovnik, U. Simončič, H. Kos, J. Jamšek, M. Kramberger, M. Brendel, V. Camacho, R. Vandenberghe, V. Garibotto, M. Ochoa-Figueroa, A. Padovani, S. Morbelli, D. Ferreira, M. Trošt (Ljubljana, Slovenia)
The development of an electronic motor symptoms diary for Parkinson’s disease using qualitative patient insights

B. Byrom, M. Pereira, P. Reksoprodjo, L. Fredane, R. Hauser (Blue Bell, USA)
The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians

T. Tezuka, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)
The East London Parkinson Disease Project: updated results from engaging a diverse population in research

A. Zirra, KC. Dey, T. Haque, E. Camboe, A. Ben-Joseph, J. Kahan, B. Huxford, S. Ganesh, C. Edwards, C. Budu, C. Simonet, DA. Gallagher, S. Waters, AJ. Lees, S. Ali, T. Boyle, RS. Weil, N. Mukadam, CR. Marshall, AJ. Noyce (London, United Kingdom)
The Effect of an Exogenous Ketone Supplement on Gut Microbiota in Parkinson’s disease, a Pilot Study

V. Vedam-Mai, M. Beke, V. Mai, P. Mackie, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)
The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder

E. Sandoval, C. Josephs, T. Lin (Tucson, USA)
The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)
The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study

M. Dumican, T. Reyers, A. Malczewski (Kalamazoo, USA)
The Effect of Modulating Alpha-synuclein Aggregation on Clinical Outcome in the Presence of Standard-of-care Dopaminergic Therapy in Parkinson’s Disease. A Quantitative Systems Pharmacology Approach.

H. Geerts, S. Short (Princeton, USA)
The Effect of Stochastic Resonance Stimulation in Neural Control of Balance During Walking in Parkinson Disease

E. Alsaqabi, S. Dibianca, A. Sansare, K. Verma, J. Jeka, H. Reimann (Newark, USA)
The Effect of Subjective Postural Vertical on Forward Flexed Posture in Parkinson’s disease

M. Shiraishi, K. Mikami, H. Kamo, Y. Okuma, T. Tsunemi, K. Fujimoto, T. Kamo, Y. Yokota, S. Nogawa, T. Osada, M. Seki, H. Nagayama, T. Hatano, H. Nakajima, K. Suzuki, T. Yamamoto, Y. Yamano, N. Hattori, M. Ijima (Kawasaki City, Japan)
The Effects of Baduanjin on Fine Motor Skills in Mild and Moderate Parkinson’s Disease

JUN. Li, KF. Li, HZ. Chen, WM. Yang (Hefei, China)
The effects of DL-3-n-butylphthalide in patients with mild cognitive impairment due to Parkinson’s disease: A multicenter, randomized, double-blind, placebo-controlled trial

C. Han, Y. Xia, J. Wu, Y. Sun, L. Kou, J. Huang, Q. Wang, E. Xu, H. Yu, Q. Ye, X. Luo, H. Ma, H. Chen, L. Wang, T. Wang (wuhan, China)
The Fazekas scale score and the occurrence of adverse events after MRgFUS thalamotomy, is there a relationship?

C. Ribacoba Díaz, A. Fernández Revuelta, M. Yus Fuertes, C. Pérez García, A. Trondin, E. López Valdés, R. García-Ramos García (Madrid, Spain)
The Feasibility and Practical utility of Virtual Visits for Patients with Parkinson’s disease in Different World Regions

A. Garcia-Bustillo, J. Youn, J. Hyeon, L. Oyatoye, N. Okubadejo, A. Shalash, Z. Aldaajani, A. Cardozo, M. Spindler, Z. Mari, M. Essan, E. Cubo (Burgos, Spain)
The Feasibility of ICA in Parkinson’s Disease fMRI

A. Kim, K. Shivok, T. Liang, R. Sergott, L. Singanamala, I. Fayed, C. Matias, C. Wu, L. Krisa, M. Alizadeh (Villanova, USA)
The first Indian patient with Hereditary Spastic Paraparesis type 42 due to a de novo SLC33A1 variant

A. Agarwal, P. Sharma, D. Garg, A. Garg, M. Faruq, A. Srivastava (New Delhi, India)
The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

N. Louie, J. Solle, S. Bandrés-Ciga (New York, USA)
The Freezing of Gait Change of Direction (FOG-COD) Test: A Novel Measure to Predict Falls

R. Hand, H. Smith (Philadelphia, USA)
The functional and lipidome signature of GBA1 mutant dopaminergic neurons

G. Uras, S. Lucas-Del-Pozo, F. Fierli, S. Koletsi, V. Lentini, P. Caboni, C. Manis, D. Di Lisa, A. Andolfi, L. Pastorino, A. Schapira (London, United Kingdom)
The functional consequences of the ‘African GBA1 allele’ of rs3115534 in Parkinson’s Disease

M. Radefeldt, L. Demuth, R. Al-Ali, S. Fischer, C. Beetz, P. Bauer (Rostock, Germany)
The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)
The HIIT-Home4Parkinson’s study

C. Harpham, L. Connolly, H. Gunn, J. Marsden (Plymouth, United Kingdom)
The Impact of Apathy and Impulsivity on Caregivers in Atypical Parkinsonian Syndromes

M. Manconi, J. Donnelly, L. Massey, K. Tluchowska, S. Anugu, J. Rowe, B. Ghosh (Southampton, United Kingdom)
The Impact of Bilateral STN- Deep Brain Stimulation on Motor Symptoms and Quality Of Life in Advanced Parkinson’s Disease: A Single Center’s Experience

M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)
The Impact of Camp Lejeune Toxins on the Development of Parkinsonisms and Movement Disorders

K. Colletta, J. Hirschey, A. Raedy, A. Siddiqui, F. Weaver, S. Kletzel (Hines, USA)
The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)
The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life

M. Schiess, S. Bick, J-P. Azulay, S. Palfi, T. Witt, A. López Ríos, F. Farrokhi, B. Bretscher, G. Hilleren, T. Weaver (Houston, USA)
The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor

A. Dave, J. Frey, J. Yu, J. Lopes, C. Hess (Plainsboro, USA)
The Impact of Drug Interactions on the results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes

I. Kang, D. Bega (Chicago, USA)
The impact of long-term continuous subcutaneous apomorphine infusion on the reduction of remaining medications in levodopa equivalent dosage and on increasing plasma vitamin B12 levels in patients with advanced Parkinson’s disease

O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)
The impact of multimodal forms of art therapy on treatment outcomes and quality of life in Parkinson’s disease

L. čondić Jurjević, S. Telarović (Sisak, Croatia)
The Impact of Parkinson’s Disease on Causal Perception

Z. Rostami, M. Vaziri Pashkam, M. Salari (Tehran, Islamic Republic of Iran)
The Impact of Standardized Recommendations on the Management of Initial and Refractory Pediatric Status Dystonicus

K. Yang, N. Alazri, L. Vogt, Z. Zaman, V. Quiroz, C. Gorodetsky, D. Ebrahimi-Fakhari (Boston, USA)
The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation

F. Yazdanian, A. Enriquez-Marulanda, N. Dehmamy, J. Shils, R. Alterman (boston, USA)
The Impact of VPS35 D620N Mutation on Alternative Autophagy and its Reversal by Estrogen in Parkinson’s Disease

T. Shiraishi, K. Bono, Y. Iguchi, H. Okano (Minato-ku, Japan)
The Inhibition of Mitochondrial NLRP3 Inflammasome Decreases Dopaminergic Cell Death in a 6-OHDA Mouse Model of Parkinson’s Disease.

E. Dalle, O. Ondoua Nguele, H. Bayaga (Yaounde, Cameroon)
The Intention Component of Postural Tremor in Essential Tremor

K. Valestrino, P. Kassavetis (Salt Lake City, USA)
The international validation of the “Stepped Care” toolkit for comprehensive real life clinical care: bridging massive unmet need in care of Parkinson’s disease.

K. Poplawska-Domaszewicz, MA. Qamar, L. Batzu, A. Shalash, Y. Lau, C. Falup-Pecurariu, A. Rekik, I. Boura, C. Spanaki, J. Chacko, C. Rodriguez-Blazquez, D. Urso, R. van Coller, D. Trivedi, V. Leta, W. Kozubski, S. Michalak, J. Slawek, C. Padmakumar, S. Gangadharan, K. Koh, C. Lazacano-Ocampo, A. Sauerbier, H. Dafsari, Y. Tsuboi, N. Mostyn, K. Ray Chaudhuri (Poznan, Poland)
The Landscape of Interdisciplinary Care for Atypical Parkinsonism: A Qualitative Study from the CurePSP Centers of Care

D. Shpiner, J. Shurer, F. Ali, M. Barrett, A. Brown, A. Duquette, J. Fleisher, G. Lamotte, A. Pantelyat, S. Reichwein, F. Rodriguez-Porcel, J. Siddiqui, M. Sklerov, C. Spears, T. Virmani, R. Akhtar (Miami, USA)
The Landscape of Neurodegeneration with Brain Iron Accumulation in Indian patients: Lessons from a Multicentric Cross-sectional Study

D. Garg, A. Agarwal, J. Ganguly, R. Kandadai, R. Rajan, S. Kola, D. Radhakrishnan, S. Bhowmick, M. Chandarana, S. Desai, V. Paramanandam, P. Basu, A. Saini, E. Arunmozhimaran, S. Garg, S. Mudassir, L. Sahoo, S. Sharma, H. Kumar, R. Borgohain, A. Garg, P. Kukkle, A. Srivastava (New Delhi, India)
The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy

P. Alster, D. Otto-ślusarczyk, A. Drzewińska, K. Duszyńska-Wąs, A. Wiercińska-Drapało, M. Struga, N. Madetko-Alster (Warszawa, Poland)
The LRRK2 I1371V mutation alters membrane dynamics and inflammatory profile of astrocytes differentiated from LRRK2-I1371V PD Patient iPSCs

R. Banerjee, V. Holla, N. Kamble, R. Yadav, P. Pal, I. Datta (Bengaluru, India)
The neural contributions to fear of falling avoidance behavior in Parkinson’s disease: preliminary evidence from a mobile neuroimaging paradigm

C. Papantonatos, S. Carlson, YF. Chiu, N. Fritz, D. Peterson, J. Longhurst (Saint Louis, USA)
The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings

R. Kumar, A. Kanojia (Darbhanga, India)
The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET

J. Dalenberg, D. Peretti, L. Marapin, S. Jonker, E. Timmers, A. Vander Stouwe, M. Tijssen (Groningen, Netherlands)
The NINDS Approach to Therapeutic Development for Ultra-Rare Neurological Disorders, Bridging Translational and Clinical Frontiers in Gene-based Therapy

HJ. Cho, A. Videnovic, M. Cudkowicz, C. Coffey, D. Klements, M. Chase, J. Ohayon, C. Boshoff, A. Tamiz, C. Wright (Rockville, USA)
The novel Gait Cycle Detection Network (GCDN) for Video based gait Analysis based on single 2D RGB video

DY. Kim, R. Yu, YS. Lee, YK. Kim, JH. Shin, C. Hansen, W. Maetzler (Suwon, Republic of Korea)
The Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons with REM Sleep Behavior Disorder (RBD)

J. Cedarbaum, B. Koo, L. Zhang, K. Mead, S. Patel, V. Reddy, D. Hafler (New Haven, USA)
The potential role of monocytes a-synuclein and lipids as predictors of PD.

S. Lucas-Del-Pozo, G. Uras, D. Moreno-Martinez, F. Fierli, S. Koletsi, C. Manis, P. Caboni, D. Hughes, A. Schapira (London, United Kingdom)
The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.

E. Assey, R. Morton, J. Josephat, R. Valecha (Kilimanjaro, United Republic of Tanzania)
The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)
The Profile of Cerebellar Ataxia in Neurology Patients at National Tertiary Referral Hospital in Indonesia

I. Permatasari, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)
The Prospect of Exoskeletons for Individuals with Parkinson’s Disease: A Comprehensive Review

MYA. Amine, G. Bekheet, M. Sadek, S. Kastantin (Giza, Egypt)
The Protective Effect of Sutherlandia frutescens in a Rotenone-Induced Rat Model of Parkinson’s Disease.

L. Darbinyan, L. Manukyan, K. Simonyan, L. Hovhannisyan, V. Sarkisian, L. Hambardzumyan (Yerevan, Armenia)
The Protective Role of Lysosomal Damage Response in Preventing α-Synuclein Propagation

K. Kakuda, K. Ikenaka, C. Aguirre, C. Choong, Y. Kimura, J. Doi, H. Mochizuki (Suita, Japan)
The Purely Thermodynamic Anti-prionic Mode of Action for the Treatment of Parkinson’s Disease and other Neurodegenerative Diseases

D. Willbold (Jülich, Germany)
The relationship between dimensions of mental health and markers of Parkinson’s disease risk in the UK Biobank

B. Attaallah, S. Waters, C. Marshall, A. Noyce (London, United Kingdom)
The relationship between pain threshold and striatal dopamine function in Parkinson’s Disease

H. Kawasaki, Y. Sakasai, S. Fujita, R. Yokoyama, K. Seo, Y. Ito, T. Yamamoto (moroyama, Japan)
The Role of a Social Worker in a Deep Brain Stimulation Multidisciplinary Team

A. Currie, R. Burke, A. Martinez Nunez, A. Mckay, M. Okun (Gainesville, USA)
The role of cognitive functions on the outcomes of an intensive multidisciplinary rehabilitation program for people with Parkinson’s disease

L. Ricciardi, P. Ortelli, MC. Campo, D. Ferrazzoli, F. Morgante, J. Goldman, D. Volpe (London, United Kingdom)
The Role of Cortisol a Mediator in Influencing Cognitive Function

DT. Akramova (Tashkent, Uzbekistan)
The role of extracellular vesicles in the progression of Parkinson’s disease

T. Tsunemi, Y. Ishiguro, A. Yoroisaka, T. Shimada, F. Feng, W. Akamatsu, N. Hattori (Tokyo, Japan)
The role of LRRK2 in regulating microglial activity in Parkinson’s disease

S. Brooker, A. Thomas, D. Krainc (Chicago, USA)
the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)
The role of pathology validation on the association between smoking and Parkinson’s Disease

P. Pecoraro, S. Carbone, F. Alessi, V. Di Lazzaro, L. Di Biase (Rome, Italy)
the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms

N. Palomba, E. Bianchini, D. Rinaldi, C. Strafella, V. Caputo, F. Garramone, P. Lombardo, F. Nicoletti, E. Giardina, T. Esposito, F. Pontieri, M. Alborghetti ()
The Spatiotemporal Characteristics of Floor Sitting Rising in Parkinson’s Disease (PD)

J. Alomar, D. Wani, T. Yu, S. Leung, L. Romero, S. El-Feky, J. Wong, K. Pu, L. Quinn (New York City, USA)
The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)
The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease

K. Seo, S. Emoto, K. Abe, T. Ishii, M. Miki, M. Hara, T. Yamamoto (Saitama, Japan)
The Use of Biometric Feedback Devices for Stratification of Deep Brain Stimulation (DBS) Eligibility and Treatment Response in Parkinson Disease

E. Kolesnick, H. Ooi, M. Rashid, K. Pain, H. Sarva, A. Deik (New York, USA)
The use of modelling in Huntington’s disease

D. Guest, S. Sathe, C. Sampaio, J. Warner (Princeton, USA)
The value of DaT SPECT in rare movement disorders: acquired diseases

E. Ardila Jurado, L. Zünd-Hofer, F. Brugger, G. Kägi (St. Gallen, Switzerland)
The Yips in Golf: Is it a Task-Specific Dystonia ?

E. van Wensen (Apeldoorn, Netherlands)
Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)
Therapeutic effects of PNF techniques versus standard physiotherapy exercise on diaphragmatic muscle activity in in the treatment young onsets of Parkinsons survivors

T. Karthikeyan (Gurugram, India)
Therapeutic restoration of Faecalibacterium prausnitzii in Parkinson’s disease using targeted fructoligosaccharides: a double-blind, placebo-controlled, cross-over trial

J. O'Sullivan, N. Jayabalan, N. Birch, D. Mondhe, A. Lehn, R. Gordon, R. Adan (Brisbane, Australia)
Three-Year Progression of the Postural Control Alterations in Hereditary Spastic Paraplegias

D. Cubillos-Arcila, V. Feijó Martins, A. Ivaniski-Mello, G. Dariva Machado, V. Bielefeldt Leotti, L. Peyré-Tartaruga, J. Morales Saute (Porto Alegre, Brazil)
Time To Access Deep Brain Stimulation Surgery for Movement Disorders: A Canadian Single Center Study

P. Torabi, K. Yen, J. Miyasaki, T. Sankar, A. Shetty, F. Ba (Edmonton, Canada)
Time To Rethink the Measurement of Tremor in Early-Stage Parkinson’s Disease

N. Massat, F. La Gamba, M. Key Prato, T. Morel (Slough, United Kingdom)
Time-Restricted Eating in Huntington’s Disease: Review of the Literature and a Proposed Clinical Trial

R. Wells, L. Neilson, A. Mchill, A. Hiller (Portland, USA)
Tissue-Engineered Nigrostriatal Pathways: An Anatomically-Inspired Model of Synucleinopathy in Human Neurons

D. Chouhan, A. Bello, F. Laimo, S. Karandikar, R. Patel, K. Browne, K. Cullen, J. Duda (Philadelphia,, USA)
TM9SF2 Knockdown Decreases Pathological Alpha-synuclein Aggregation In Vivo

C. Sortwell, R. Kumaran, F. Manfredsson, C. Kemp, M. Benskey, J. Patterson, A. Stoll, J. Howe, N. Kuhn, K. Luk, M. Cookson (Grand Rapids, USA)
To develop and study the efficacy of Telephonic Psychotherapy on the Global Neuropsychological functioning of PD Patients: An RCT

R. Hazrati, R. Makkar, A. Nehra (New Delhi, India)
TOPAS-MSA: Targeting Oligomer Pathology of Alpha-Synuclein – A Study Evaluating the Safety and Efficacy of Emrusolmin in Patients with Multiple System Atrophy

J. Levin, T. Matthias, H. Knebel, S. Barash, L. Marinelli, A. Ahn, A. Giese, M. Chen, J. Nettleship ()
Touchscreen performance in people with Parkinson’s Disease

N. Cohen, R. Kizony (Haifa, Israel)
Tractography-guided versus Clinical Determination of the Most Effective Contact for Tremor Control in Patients with Deep Brain Stimulation – A Clinical Trial

C. Vander Linden, T. Berger, TA. Dembek, GA. Brandt, J. Strelow, JC. Baldermann, H. Jergas, V. Visser-Vandewalle, MT. Barbe, JN. Petry-Schmelzer (Cologne, Germany)
Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report

C. Bedeschi, P. Junior (Barueri, Brazil)
Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson’s Disease

C-H. Tsai, H-C. Huang, M-K. Lu, J-R. Duann, S-T. Tsai, B-L. Liu (Taichung, Taiwan)
Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease

S. Antipenko, A. Frohlich, M. Sklerov (Chapel Hill, USA)
Transcranial magnetic stimulation target comparison identifies motor network reorganization associated with behavioral improvement in writer’s cramp dystonia

N. Bukhari-Parlakturk, P. Mulcahey, M. Lutz, R. Ghazi, Z. Huang, M. Dannhauer, P. Termsarasab, B. Scott, Z. Simsek, S. Groves, M. Lipp, M. Fei, T. Tran, E. Wood, L. Beynel, C. Petty, J. Voyvodic, L. Appelbaum, H. Al-Khalidi, S. Davis, A. Michael, A. Peterchev, N. Calakos (Durham, USA)
Transcranial Sonography of the Substantia Nigra and Vagus Nerve Ultrasonography as Complementary Diagnosis for Parkinson’s Disease.

W. Quaresma, G. Castro, E. Santos, A. Felicio, J. Duarte, B. Gomes, B. Santos-Lobato, J. Quaresma, L. Krejcová (Sao Paulo, Brazil)
Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.

TL. Ho, HD. Nguyen, EJ. Ko, YE. Kim (Jeju-si, Republic of Korea)
Transcriptomic and Proteomic Profiling for Effective Deep Brain Stimulation in Parkinson’s Disease

L. Luo, M-Y. Lai, D. Palanisamy, B. Benitez (Boston, USA)
Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)

M. Smith, A. Cullen, G. Portlock, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Transforming Parkinson’s Care in Africa: Establishing a Global Virtual Support Group for Africans Impacted by Parkinson’s Disease

E. Bruce, M. Cham, T. Park, N. Fothergill-Misbah (Sogakope, Ghana)
Transforming Parkinson’s Care in Africa: Establishing the First Ever Support Group for People With Parkinson’s Disease and Their Caregivers in Tanzania.

M. Shayo, K. Haukila, T. Park, R. Walker, N. Fothergill-Misbah (Moshi, United Republic of Tanzania)
Transition from Zinc Salts to Trientine Tetrahydrochloride in Wilson Disease: Clinical and Biochemical Effects over Two Years – the ZICUP study

A. Poujois, MA. Obadia, N. Oussedik-Djebrani, E. Couchonnal-Bedoya, F. Ory-Magne, D. Debray (France, France)
Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data

R. Mehanna, R. Hauser, E. Furr Stimming, L. Citrome, E. Kayson, J. Goldstein, O. Klepitskaya, S. Hinton, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)
Treatment of Craniofacial Dystonias with Methylphenidate: A Case Series.

R. Lopez-Castellanos, H. Jinnah, M. Thayani (Atlanta, USA)
Treatment of Post-hypoxic Myoclonus using Bilateral Subthalamic Nuclei Deep Brain Stimulation

E. Tharp, J. Gavvala, M. Hafeez, S. Pati, S. Lhatoo, N. Tandon, R. Mehanna (Houston, USA)
Treatment of Severe Tardive Syndrome with Pallidotomy: A Case Report

K. Nalamada, S. Yarlagadda, R. Gross, P. Aia, P. Beach, S. Factor (Atlanta, USA)
Treatment of status dystonicus in children using pallidal deep brain stimulation

A. Gamaleya, A. Poddubskaya, E. Makashova, S. Asriyants, A. Tomskiy (Moscow, Russian Federation)
Treatment Patterns and Comorbidities Associated with Multiple System Atrophy: A Comparative Study

S. Kaplan, H. Xie, A. Kumar (Netanya, Israel)
Treatment Patterns in Essential Tremor: Real-World Evidence from Germany

JS. Becktepe, S. Müller, T. Wilke, E. Zhuleku, K. Appiah, K. Mcdonald, N. Dzimitrowicz, J. Marshall, J. Sabater, LM. Barbato, TA. Saifee (Kiel, Germany)
Treatment Patterns With Long-Term Foslevodopa/Foscarbidopa Use in Parkinson’s Disease

J. Aldred, T. Henriksen, M. Bouchard, J. Martínez-Castrillo, M. Soileau, D. Standaert, L. Bergmann, R. Gupta, P. Kukreja, M. Shah, S. Isaacson (Spokane, USA)
Tremor and dizziness in a psychiatric patient

O. Toth-Basa, A. Centea, M. Bonea, L. Perju-Dumbrava (Cluj-Napoca, Romania)
Tremors Vs. Tremors: the first music album from Parkinson’s tremors

C. Dore, J. Thomas, S. Rose, J. Leitão, C. Hugill, C. Lambert (London, United Kingdom)
Tremulous Machado-Joseph Disease

V. Procaci, L. de Farias, S. da Costa, O. Barsottini, J. Pedroso (Sao Paulo, Brazil)
Trend-Analysis of Movement Disorders, Malignant Neoplasms and Mortality from 1999-2020

M. Ammar-Ur-Rahman, L. Munir, A. Khalid, A. Chaudhary (Lahore, Pakistan)
Trends in Physiotherapy Interventions and Medical Costs for Parkinson’s Disease in South Korea, 2011–2020

DW. Ryu, MJ. Lee, JS. Park, DL. Yoo, SM. Cheon ()
Trihexyphenidyl Use in a Parkinsonian Phenotype of Gerstman-Sträussler-Scheinker Syndrome

P. Atit, S. Aradi (Tampa, USA)
Triple threat: A rare case of a patient with 3 co-existent autoimmune antibodies causing autonomic and movement disorder

YK. Kim, KC. Colletta (Maywood, USA)
TrkB modulator OT-003 reduces dopaminergic cell loss, mitochondrial stress, alpha-synuclein aggregation and motor dysfunction in Parkinson’s disease models.

T. Pfeiffer, M. Ho, E. Duckworth, L. Tear, Z. Zahariev, L. Khederlarian, A. Plowright (Sevenoaks, United Kingdom)
TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

SJ. Song, YE. Kim (Anyang, Republic of Korea)
Two Cases of Moyamoya Syndrome-Associated Chorea and Dystonia

M. Qureshi, S. Radmard (Albany, USA)
Two parallel nigrostriatal subcircuits mediate the arousal effect of dopaminergic neurons in substantia nigra pars compacta

HS. Liu, JW. Li, ZA. Hu, RC. Ren, XN. Xiong (Wuhan, China)
Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease

L. Lachance, P. Huot (Montreal, Canada)
Two-year longitudinal evaluation of ataxia and brain structural changes in RFC1-related disorder

C. Lobo, T. Rezende, G. Schmitt, P. Matos, F. Lima, A. Martinez, O. Barsottini, JL. Pedroso, W. Marques Jr, M. França Jr (Campinas, Brazil)